NDC 70954-159-40 - Clorazepate Dipotassium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70954-159
- Requested NDC
- 70954-159-40
- Package NDCs from labels
- 70954-159-10, 70954-159-20, 70954-159-30, 70954-159-40, 70954-159-50
- Manufacturer
- ANI Pharmaceuticals, Inc. | Novitium Pharma LLC
- Effective date
- 2025-08-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Clorazepate Dipotassium - ANI Pharmaceuticals, Inc. | Novitium Pharma LLC | ANI Pharmaceuticals, Inc. | Novitium Pharma LLC | 2025-08-12 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70954-159-10 | Clorazepate Dipotassium | 100 in 1 BOTTLE | TABLET | 100 | 13 | |
| 70954-159-20 | Clorazepate Dipotassium | 500 in 1 BOTTLE | TABLET | 500 | 13 | |
| 70954-159-30 | Clorazepate Dipotassium | 30 in 1 BOTTLE | TABLET | 30 | 13 | |
| 70954-159-40 | Clorazepate Dipotassium | 1 in 1 BLISTER PACK | TABLET | 1 | 13 | |
| 70954-159-50 | Clorazepate Dipotassium | 30 in 1 BOX, UNIT-DOSE | TABLET | 30 | 13 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70954-159-10 | EA - Each | 70954-159 | 4d201f37-b4a8-49b9-a0d4-427f95511aea | 1 | 2022-07-06 |
| 70954-159-30 | EA - Each | 70954-159 | 66ddfa29-e746-4559-a6b5-94c2869fe137 | 1 | 2023-09-05 |
| 70954-159-40 | EA - Each | 70954-159 | ef021671-4401-4255-978d-e5a694e8b1fc | 1 | 2025-07-08 |
| 70954-159-50 | EA - Each | 70954-159 | 195dbf33-cf57-4b67-aabb-f74d7704ab06 | 1 | 2025-07-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Schuessler Tissue Salts Comb D Skin Disorders | KALI MURIATICUM,KALI SULPHURICUM,CALCAREA SULPHURICA,SILICEA | Martin & Pleasance Pty Ltd | 617303f8-4463-4a1e-a502-44abc181d91f | 2025-08-13 | Warnings | ETJ7Z6XBU4 660YQ98I10 |
| Schuessler Tissue Salts Comb D Skin Disorders | KALI MURIATICUM,KALI SULPHURICUM,CALCAREA SULPHURICA,SILICEA | Martin & Pleasance Pty Ltd | 03153d92-dc68-4b84-a8c9-634b1ffd7da1 | 2025-08-13 | Warnings | ETJ7Z6XBU4 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Henry Schein, Inc. | bf8e8ac7-e6a8-4571-a0ea-7bcab89290f6 | 2025-08-12 | Warnings, Adverse reactions | 660YQ98I10 |
| Clorazepate Dipotassium | CLORAZEPATE DIPOTASSIUM | ANI Pharmaceuticals, Inc. | a4b80e69-b7c7-471a-8ce8-4e992808c669 | 2025-08-12 | Boxed warning, Warnings, Adverse reactions | ANDA213730 70954-157-30 70954-159-10 70954-159-50 70954-158-50 70954-159-20 70954-157-40 70954-158-40 70954-157-10 70954-157-20 70954-159-30 70954-159-40 70954-158-30 70954-158-20 70954-158-10 70954-158 70954-159 70954-157 70954015940 197465 197466 197464 d4edcb5d-dbe9-44c4-a0a9-d3b6aba4c22d a4b80e69-b7c7-471a-8ce8-4e992808c669 63FN7G03XY |
| Cloveden Vegan Whitening Tooth | SILICA, HYDROGEN PEROXIDE, TOCOPHERYL ACETATE | Acuseplanet Inc | 3c04778b-9535-856e-e063-6294a90aa868 | 2025-08-10 | Warnings | ETJ7Z6XBU4 |
| Potassium Chloride | POTASSIUM CHLORIDE | AvKARE | 3bdfced1-6e62-9e92-e063-6294a90a28aa | 2025-08-08 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 3be29fcc-765e-8653-e063-6394a90a59d5 | 2025-08-08 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Slate Run Pharmaceuticals, LLC | 94ae03cc-b620-0dbb-e053-2a95a90a922c | 2025-08-07 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Slate Run Pharmaceuticals, LLC | 0cc57ece-f15a-4160-a5ea-8d6fa9f9e754 | 2025-08-07 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 47a87fb6-5e61-41c9-b759-10f7c74a67ce | 2025-08-05 | Warnings, Adverse reactions | 660YQ98I10 |
| Schuessler Tissue Salts Silica Cleanser and Conditioner 12 | SILICEA | Martin & Pleasance Pty Ltd | f70dcf90-bde9-404d-9ede-4113553ccbff | 2025-08-04 | Warnings | ETJ7Z6XBU4 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | American Health Packaging | 7956883f-0d31-4081-bbea-d9ea320a193b | 2025-08-04 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride for Oral Solution | POTASSIUM CHLORIDE FOR ORAL SOLUTION | Marlex Pharmaceuticals Inc | 3e78028d-21a0-ba0f-e063-6294a90aac49 | 2025-08-01 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride for Oral Solution | POTASSIUM CHLORIDE FOR ORAL SOLUTION | Marlex Pharmaceuticals, Inc. | 3e8a6f61-44eb-4b5a-e063-6294a90a4b1b | 2025-08-01 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE EXTENDED RELEASE | POTASSIUM CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 3b403d60-4246-d765-e063-6394a90a12e8 | 2025-07-31 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | A-S Medication Solutions | 162a8ab5-76cf-48fa-8487-7780ed65647e | 2025-07-31 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | A-S Medication Solutions | 14db14ba-fd0d-4b2a-9f1c-a62b3b82306f | 2025-07-31 | Warnings, Adverse reactions | 660YQ98I10 |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 985a3341-0fe0-1dd6-e053-2a95a90ad2c5 | 2025-07-25 | Warnings | ETJ7Z6XBU4 660YQ98I10 |
| SILICA MARINA | SILICON DIOXIDE | Boiron | 3aada26e-6a8e-f545-e063-6394a90a9f80 | 2025-07-24 | ETJ7Z6XBU4 | |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 7a1b4e96-c96f-6424-e053-2991aa0aef30 | 2025-07-24 | Warnings | ETJ7Z6XBU4 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.